Advertisement

Spontaneous Growth Hormone (GH) Secretion and Results of Therapy with GH in Thalassemic Patients

  • Z. Hochberg
  • M. C. J. Rudolf
  • N. Shehadeh
  • A. Hazani

Abstract

Life expectancy for patients with thalassemia major (TM) has greatly improved, and their hopes are now directed towards attainment of better quality of life. The growth retardation of many of these patient becomes a major concern for the patients, their families, and the medical care-giver.

Keywords

Growth Hormone Growth Hormone Response Growth Hormone Therapy Thalassemic Patient Thalassemia Major 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shehadeh N, Hazani A, Rudolf MCJ, Peleg I, Benderly A, Hochberg (1990) Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr Scand 79: 790–795Google Scholar
  2. 2.
    Scacchi M, Danesi L, De Martin M, Dubini A, Forni L, Masala A, Gallisai D, Burrai C, Terzoli S, Boffa C, Marzano C, Cavagnini F (1991) Treatment with biosynthetic growth hormone of short thalassemic patients with impaired growth hormone secretion. Clin Endocrinol (Oxf.) 35: 335–339CrossRefGoogle Scholar
  3. 3.
    Werther GA, Matthews RN, Burger HG, Herington AC (1981) Lack of response of non-suppressible insulin-like activity to short-term administration of human growth hormone in thalassemia major. J Clin Endocrinol Metab 53: 806–809PubMedCrossRefGoogle Scholar
  4. 4.
    Johnston FE, Hertzog KP, Malina RM (1966) Longitudinal growth in thalassemia major. Am J Dis Child 122: 396–399Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Z. Hochberg
  • M. C. J. Rudolf
  • N. Shehadeh
  • A. Hazani

There are no affiliations available

Personalised recommendations